Literature DB >> 10580382

Rhodopeptins (Mer-N1033), novel cyclic tetrapeptides with antifungal activity from Rhodococcus sp. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

H Chiba1, H Agematu, R Kaneto, T Terasawa, K Sakai, K Dobashi, T Yoshioka.   

Abstract

Five novel cyclic tetrapeptides, named rhodopeptin C1, C2, C3, C4 and B5, were isolated from a strain named Rhodococcus sp. Mer-N1033. They are a novel type of cyclic tetrapeptide composed of a beta-amino acid and three usual alpha-amino acids. Rhodopeptins show high in vitro antifungal activity against Candida albicans and Cryptococcus neoformans, whereas they show no activity against bacteria.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10580382     DOI： 10.7164/antibiotics.52.695

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  11 in total

Review 1.  Bioactive cyclobutane-containing alkaloids.

Authors:  Valery M Dembitsky
Journal:  J Nat Med       Date:  2007-09-05       Impact factor: 2.343

2.  Solid-phase synthesis, cyclization, and site-specific functionalization of aziridine-containing tetrapeptides.

Authors:  Benjamin K W Chung; Christopher J White; Andrei K Yudin
Journal:  Nat Protoc       Date:  2017-05-24       Impact factor: 13.491

Review 3.  Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.

Authors:  Ricardo Ribeiro; Eugénia Pinto; Carla Fernandes; Emília Sousa
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

4.  The antimicrobial activity of heterotrophic bacteria isolated from the marine sponge Erylus deficiens (Astrophorida, Geodiidae).

Authors:  Ana Patrícia Graça; Flávia Viana; Joana Bondoso; Maria Inês Correia; Luis Gomes; Madalena Humanes; Alberto Reis; Joana R Xavier; Helena Gaspar; Olga M Lage
Journal:  Front Microbiol       Date:  2015-05-07       Impact factor: 5.640

5.  Extraction and bioactive profile of the compounds produced by Rhodococcus sp. VLD-10.

Authors:  Bokka Yellamanda; Muvva Vijayalakshmi; Alapati Kavitha; Dorigondla Kumar Reddy; Yenamandra Venkateswarlu
Journal:  3 Biotech       Date:  2016-12-10       Impact factor: 2.406

6.  Enrichment of beneficial bacteria in the skin microbiota of bats persisting with white-nose syndrome.

Authors:  Virginie Lemieux-Labonté; Anouk Simard; Craig K R Willis; François-Joseph Lapointe
Journal:  Microbiome       Date:  2017-09-05       Impact factor: 14.650

7.  Bio-Guided Isolation of Antimalarial Metabolites from the Coculture of Two Red Sea Sponge-Derived Actinokineospora and Rhodococcus spp.

Authors:  Hani A Alhadrami; Bathini Thissera; Marwa H A Hassan; Fathy A Behery; Che Julius Ngwa; Hossam M Hassan; Gabriele Pradel; Usama Ramadan Abdelmohsen; Mostafa E Rateb
Journal:  Mar Drugs       Date:  2021-02-12       Impact factor: 5.118

8.  Rhodococcus comparative genomics reveals a phylogenomic-dependent non-ribosomal peptide synthetase distribution: insights into biosynthetic gene cluster connection to an orphan metabolite.

Authors:  Agustina Undabarrena; Ricardo Valencia; Andrés Cumsille; Leonardo Zamora-Leiva; Eduardo Castro-Nallar; Francisco Barona-Gomez; Beatriz Cámara
Journal:  Microb Genom       Date:  2021-07

9.  An inhibitory compound produced by a soil isolate of Rhodococcus has strong activity against the veterinary pathogen R. equi.

Authors:  Amber L Ward; Pushpavathi Reddyvari; Ralitsa Borisova; Abbas G Shilabin; Bert C Lampson
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

Review 10.  Biotechnology of Rhodococcus for the production of valuable compounds.

Authors:  Martina Cappelletti; Alessandro Presentato; Elena Piacenza; Andrea Firrincieli; Raymond J Turner; Davide Zannoni
Journal:  Appl Microbiol Biotechnol       Date:  2020-09-12       Impact factor: 4.813
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.